Noritaka Baba

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Developing effective drug therapies for arrhythmic diseases is hampered by the fact that the same drug can work well in some individuals but not in others. Human induced pluripotent stem (iPS) cells have been vetted as useful tools for drug screening. However, cardioactive drugs have not been shown to have the same effects on iPS cell-derived human(More)
  • 1